Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Common cold virus can cause deadly pneumonia in transplant patients, study shows

The common cold is a major source of annoyance for most of us, but new research has found that the most prevalent respiratory infection can be far worse than a stuffy nose for one sector of the population — bone marrow transplant patients.

8 Mar 2017

Early death from pediatric cancer subtypes more likely to happen than previously reported

Treatments for childhood cancers have improved to the point that 5-year survival rates are over 80 percent. However, one group has failed to benefit from these improvements, namely children who die so soon after diagnosis that they are not able to receive treatment, or who receive treatment so late in the course of their disease that it is destined to fail.

8 Mar 2017

Penn researchers identify genome-wide changes caused by high-fat diet

By comparing two strains of mice -- one that becomes obese and diabetic on a high-fat diet and another resistant to a high-fat regimen -- researchers from the Perelman School of Medicine at the University of Pennsylvania identified genome-wide changes caused by a high-fat diet.

8 Mar 2017

Study finds causes for early readmission among older adults discharged to post-acute care facilities

More than 25 percent of Medicare beneficiaries who are admitted to the hospital are sent to a post-acute care facility (a health facility like a rehabilitation or skilled nursing center used instead of a hospital) after being discharged.

7 Mar 2017

Professional IPM no better in decreasing asthma in children than do-it-yourself mouse allergen reduction

The results of a new study reveal that a professional pest management intervention was no better in decreasing asthma symptoms in children allergic to mice than teaching families how to reduce the level of allergens shed by mice in the home on their own.

7 Mar 2017

McMaster researchers find new way to combat world's worst infectious diseases

McMaster University researchers have found a new way to treat the world's worst infectious diseases, the superbugs that are resistant to all known antibiotics.

6 Mar 2017

Losing Energy vs. Losing Samples, Trade-offs in Sample Storage

An interview with Jean Fallacara, CEO, discussing how Z-SC1 help to ensure safe sample storage at ultra-low temperatures, conducted by James Ives, MPsych

6 Mar 2017

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

3 Mar 2017

Innovative ways to target antibiotic resistance in short term

There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.

3 Mar 2017

WHO releases first ever list of antibiotic-resistant 'priority pathogens'

The World Health Organization today published its first ever list of antibiotic-resistant “priority pathogens”—a catalogue of 12 families of bacteria that pose the greatest threat to human health.

3 Mar 2017

Study increases understanding of how air pollution affects human health

Researchers from the University of Leicester have for the first time discovered that bacteria that cause respiratory infections are directly affected by air pollution - increasing the potential for infection and changing the effectiveness of antibiotic treatment.

2 Mar 2017

Cigarette smoke blocks lung's self-healing that can lead to COPD

Smoke from cigarettes blocks self-healing processes in the lungs and consequently can lead to chronic obstructive pulmonary disease (COPD).

2 Mar 2017

High-dose flu vaccine appears to be effective at preventing post-influenza deaths among older adults

The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare beneficiaries published in The Journal of Infectious Diseases.

2 Mar 2017